Fig. 1
From: Impact of HCV elimination on metabolism markers in people living with HIV
Flow chart of patients involved in this study. Patients were grouped according to their viral status: Chronic HCV (CHC) who cleared HCV with direct-acting antivirals agents (DAAs) and HIV + patients who spontaneously clarify HCV infection (SC). Samples were collected at baseline (CHCb and SCb) and 48 weeks after achieving a sustained virological response (CHCf) or one year of follow-up (SCf). A control group PLHIV (HIV +) without a previous HCV infection was included.
